Cargando…
High Levels of Hyaluronic Acid Synthase-2 Mediate NRF2-Driven Chemoresistance in Breast Cancer Cells
Hyaluronic acid (HA), a ligand of CD44, accumulates in some types of tumors and is responsible for tumor progression. The nuclear factor erythroid 2-like 2 (NRF2) regulates cytoprotective genes and drug transporters, which promotes therapy resistance in tumors. Previously, we showed that high levels...
Autores principales: | Choi, Bo-Hyun, Ryoo, Ingeun, Sim, Kyeong Hwa, Ahn, Hyeon-jin, Lee, Youn Ju, Kwak, Mi-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252875/ https://www.ncbi.nlm.nih.gov/pubmed/35768333 http://dx.doi.org/10.4062/biomolther.2022.074 |
Ejemplares similares
-
Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells
por: Ryoo, In-geun, et al.
Publicado: (2015) -
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
por: Kim, Donghyeok, et al.
Publicado: (2018) -
The Sensitivity of Cancer Cells to Pheophorbide a-Based Photodynamic Therapy Is Enhanced by NRF2 Silencing
por: Choi, Bo-hyun, et al.
Publicado: (2014) -
Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance
por: Ryoo, In-geun, et al.
Publicado: (2016) -
The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
por: Jung, Kyeong-Ah, et al.
Publicado: (2010)